Montgomery County pushes $10B biotech 'science city'

A group of officials from Johns Hopkins University is joining forces with a group of biotech business leaders in the state to move ahead today with plans to build a $10 billion, 17.5 million-square-feet R&D "science city" in Maryland's Montgomery County. The county council is expected to endorse the ambitious project, which would go a long way toward making the county a biotech hub that could rival the likes of Palo Alto.

County Executive Isiah Leggett, meanwhile, is in Chicago to tout the area as a biotech leader at the annual meeting of BIO. And his delegation is being joined by chief executives from Human Genome Sciences and MedImmune, two big biotech players based in the county.

Some nearby residents are skeptical about the project, but the proposed R&D complex would neighbor a new set of buildings planned for the National Cancer Institute.

- read the story from the Washington Post

Suggested Articles

Almirall is pulling the trigger on an option to advance Dermira's lebrikizumab in Europe, a program it reckons could rake in €450 million.

Acer Therapeutics’ stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo (celiprolol).

The latest setback prompted Novartis-partnered Conatus to lay off 40% of its staff and begin looking for strategic alternatives.